- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01906619
Respiratory Physiology in Children With Febrile Seizures.
Investigation of the Respiratory Physiology of Children With and Without Febrile Seizures During Febrile Illness.
Febrile seizures occur in 2-5% of the population and are typically limited to children between 3 months and 5 years-of-age. The pathophysiological link between increased body temperature and increased seizure susceptibility is unsolved in humans. In a mouse model it has been shown that young animals had a tendency to hyperventilate thereby causing intra-cerebral hypocapnia / alkalosis and a decrease of their seizure threshold. This effect was not observed in older animals. Redressing the pCO2 (carbon dioxide partial pressure) by breathing carbon dioxide enriched air instantly stopped the seizures.
In this study the investigators want to investigate the respiratory physiology in children with febrile seizures and compare it to children who have fever but did not have febrile seizures.
The investigators hypothesize that in children with febrile seizures the rising body temperature triggers a larger increase of respiratory rate (hyperventilation) and subsequent drop in pCO2 levels.
This study could provide the basic physiological data for an interventional trial to test the efficacy of carbon dioxide inhalation to interrupt febrile seizures.
Study Overview
Status
Conditions
Detailed Description
The aim of the study is the continuous non-invasive monitoring of
- body temperature
- respiratory rate
- transcutaneous pCO2
- heart rate
- pulsoxymetric SaO2 (arterial oxygen saturation) during a febrile illness
- in children without febrile seizures and
- in children who had suffered a febrile seizure during the actual febrile illness.
Children will be recruited from the emergency units of the Charité University Hospital and a large Community Hospital, matched according to age, gender and the cause of their febrile illness and their data will enter final analysis if their body temperature rose at least once to or above 38.0 degree C and changed more than 1.0 degree C during the observational period.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Berlin, Germany, 13353
- Recruiting
- Charite Universitatsmedizin Berlin
-
Contact:
- Marret Heinold
- Phone Number: +49 30 450 539 720
- Email: marret.heinold@charite.de
-
Contact:
- Markus Schuelke, MD
- Phone Number: +4 9 30 4505 66468
- Email: markus.schuelke@charite.de
-
Principal Investigator:
- Markus Schuelke, MD
-
Sub-Investigator:
- Engelke Anne-Sophie
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Febrile illness with body temperature ≥38.0 degree C
- 50% of study population: never had a febrile seizure
- 50% of study population: simple or complex febrile seizure within one day of investigation
- Change of body temperature of ≥1.0 degree C during the monitoring period
- Provision of written informed consent by the parents or guardians of the child
- Artefact-free simultaneous measurement of respiratory rate, pCO2 (transcutaneous probe), body temperature (rectal probe), and heart rate during change of body temperature of ≥1.0 degree C.
Exclusion Criteria:
- Past history of afebrile seizures
- Past history of neonatal seizures
- Retarded psychomotor development
- Chronic respiratory disease
- Cardiologic disease
- Severe other organ disease
- Permanent medication for chronic disorder
- Therapeutic increase of inspiratory oxygen concentrations during the observational period
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Febrile illness WITH febrile seizure
The cohort comprises children aged between 3 months and 5 years who had a febrile seizure during the actual febrile disease.
|
Febrile illness WITHOUT febrile seizure
The cohort comprises children aged between 3 months and 5 years with a febrile illness who had never a febrile seizure.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of transcutaneous pCO2 per change of body temperature [mmHg/degree C]
Time Frame: First or second night of febrile illness
|
The following parameters are continuously monitored in the sleeping child at night during febrile illness: body temperature, respiratory rate, transcutaneous pCO2, heart rate, pulsoxymetric SaO2
|
First or second night of febrile illness
|
Change of respiratory rate per change of body temperature [1/sec * degree C]
Time Frame: First or second night of febrile illness
|
The following parameters are continuously monitored in the sleeping child at night during febrile illness: body temperature, respiratory rate, transcutaneous pCO2, heart rate, pulsoxymetric SaO2
|
First or second night of febrile illness
|
Change of transcutaneous pCO2 per change of respiratory rate [mmHg * sec]
Time Frame: First or second night of febrile illness
|
The following parameters are continuously monitored in the sleeping child at night during febrile illness: body temperature, respiratory rate, transcutaneous pCO2, heart rate, pulsoxymetric SaO2
|
First or second night of febrile illness
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Markus Schuelke, MD, Charite University, Berlin, Germany
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EA2_009_10
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Seizures, Febrile
-
Institut za Rehabilitaciju Sokobanjska BeogradCompletedFebrile SeizureSerbia
-
Institut za Rehabilitaciju Sokobanjska BeogradCompleted
-
Sohag UniversityCompleted
-
Tanta UniversityCompleted
-
Centre Hospitalier Universitaire DijonCompletedInfants Likely to Present Febrile ConvulsionsFrance
-
University of OuluCompleted
-
Charite University, Berlin, GermanyTerminated
-
University Hospital, ToulouseNot yet recruiting
-
Hôpital Armand TrousseauHopital Universitaire Robert-Debre; Centre Hospitalier Intercommunal Creteil; Versailles Hospital and other collaboratorsCompletedEncephalitis | Meningitis | Seizure | Febrile SeizureFrance
-
Assiut UniversityNot yet recruitingFebrile Convulsion